Pro Share Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 20,556 shares of SNDX stock, worth $283,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,556
Previous 31,600 34.95%
Holding current value
$283,672
Previous $648,000 39.04%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$17.93 - $24.81 $198,018 - $274,001
-11,044 Reduced 34.95%
20,556 $395,000
Q2 2024

Aug 13, 2024
BUY
$18.82 - $23.79 $216,204 - $273,299
11,488 Added 57.12%
31,600 $648,000
Q1 2024

May 08, 2024
BUY
$19.71 - $24.57 $90,646 - $112,997
4,599 Added 29.65%
20,112 $478,000
Q4 2023

Feb 14, 2024
BUY
$11.39 - $21.67 $27,461 - $52,246
2,411 Added 18.4%
15,513 $335,000
Q3 2023

Nov 13, 2023
BUY
$14.52 - $21.77 $1,161 - $1,741
80 Added 0.61%
13,102 $190,000
Q2 2023

Aug 10, 2023
BUY
$19.35 - $22.31 $23,142 - $26,682
1,196 Added 10.11%
13,022 $272,000
Q1 2023

May 11, 2023
SELL
$20.66 - $28.98 $20 - $28
-1 Reduced 0.01%
11,826 $249,000
Q4 2022

Feb 02, 2023
BUY
$20.64 - $26.24 $24,788 - $31,514
1,201 Added 11.3%
11,827 $300,000
Q3 2022

Nov 04, 2022
BUY
$18.51 - $24.79 $8,014 - $10,734
433 Added 4.25%
10,626 $255,000
Q2 2022

Aug 01, 2022
SELL
$13.64 - $19.48 $60,602 - $86,549
-4,443 Reduced 30.36%
10,193 $195,000
Q1 2022

May 10, 2022
SELL
$14.84 - $22.15 $31,891 - $47,600
-2,149 Reduced 12.8%
14,636 $254,000
Q4 2021

Feb 08, 2022
BUY
$15.23 - $22.47 $9,655 - $14,245
634 Added 3.93%
16,785 $367,000
Q3 2021

Nov 12, 2021
SELL
$13.87 - $19.8 $58,018 - $82,823
-4,183 Reduced 20.57%
16,151 $309,000
Q2 2021

Aug 13, 2021
BUY
$13.42 - $25.18 $73,514 - $137,936
5,478 Added 36.87%
20,334 $349,000
Q1 2021

May 14, 2021
BUY
$19.28 - $24.59 $49,761 - $63,466
2,581 Added 21.03%
14,856 $332,000
Q4 2020

Feb 09, 2021
BUY
$15.1 - $26.44 $185,352 - $324,551
12,275 New
12,275 $273,000
Q4 2018

Feb 14, 2019
SELL
$3.6 - $8.42 $40,464 - $94,640
-11,240 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$6.33 - $8.08 $6,944 - $8,863
-1,097 Reduced 8.89%
11,240 $91,000
Q2 2018

Aug 13, 2018
SELL
$6.93 - $14.63 $3,083 - $6,510
-445 Reduced 3.48%
12,337 $87,000
Q1 2018

May 14, 2018
SELL
$8.71 - $14.82 $18,334 - $31,196
-2,105 Reduced 14.14%
12,782 $182,000
Q4 2017

Feb 14, 2018
BUY
$7.8 - $12.94 $116,118 - $192,637
14,887
14,887 $130,000

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $781M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email